Table 2 |
|
| Therapy of the patients at the time of renal biopsy | |
| Therapy | Number of patients (percent) |
| No therapy | 29 (50.0) |
| Diuretics | 14 (24.1) |
| Frusemide | 12 (20.7) |
| Frusemide + Spironolactone | 1 (1.7) |
| Fluitran | 1 (1.7) |
| Steroid | 6 (10.3) |
| ARB | 3 (4.4) |
| ACE | 1 (1.7) |
| ARB + ACE | 1 (1.7) |
| CCB | 2 (3.4) |
| NSAIDs | 1(1.7) |
| Unkown | 1(1.7) |
ARB, Angiotensin receptor blocker; ACE, Angiotensin converting enzyme inhibitor; CCB, calcium channel blocker; NSAIDs, Non-steroidal anti-rheumatoid drugs.
Kuroda et al. BMC Nephrology 2012 13:118 doi:10.1186/1471-2369-13-118
